Screening mammography
This article was originally published in The Gray Sheet
Executive Summary
Flaws cited by Cochrane Collaboration review in screening mammography methodology are insufficient to reject trial results entirely, updated U.S. Preventive Services Task Force recommendations state. Released Feb. 21, the updated guidelines advocate screening mammography in women over 40 every one to two years and in women over 50 every other year. Cochrane researchers Peter Gotzsche and Ole Olsen assert in the October 2001 issue of the Lancet that no reliable evidence exists to support screening mammography (1"The Gray Sheet" October 29, 2001, p. 20). NCI Director Andrew von Eschenbach and Donald Berry, MD, M.D. Anderson Cancer Center, Houston, are among those who will testify at a Feb. 28 Senate HELP/Public Health Subcommittee hearing on the issue...